Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative indocyanine green detection of bile leakage after hepatectomy
jRCTs061210043Completed
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of indocyanine green in hepatocellular carcinoma (HCC), liver cancer and Benign hepatic neoplasm (BHN) (2 arms). Primary endpoint: Total bilirubin concentration in drainage on postoperative day 3. Started Nov 2021; status: completed.
02
Drugs
indocyanine green
03
Conditions
hepatocellular carcinoma (HCC)liver cancerBenign hepatic neoplasm (BHN)
Beyond the preview
Go deeper on jRCTs061210043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061210043.